The Tryptophan System in Cocaine-Induced Depression

Trastorno por uso de cocaína y depresión: cuando el diagnóstico clínico no es suficiente

(2020) Maria Alías-Ferri et al.   Adicciones

Predictors of response to repeated ketamine infusions in depression with suicidal ideation: An ROC curve analysis

(2020) Yanling Zhou et al.   JOURNAL OF AFFECTIVE DISORDERS

Global Burden of Disease and the Impact of Mental and Addictive Disorders

(2019) Jürgen Rehm et al.   Current Psychiatry Reports

The kynurenine pathway: a finger in every pie

(2019) Jonathan Savitz   MOLECULAR PSYCHIATRY

An immune gate of depression – early neuroimmune development in the formation of the underlying depressive disorder

(2019) Małgorzata Kowalczyk et al.   Pharmacological Reports

Novel Neuroimmunologic Therapeutics in Depression: A Clinical Perspective on What We Know So Far

(2019) Michael Roman et al.   BRAIN BEHAVIOR AND IMMUNITY

Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer

(2018) Francisco S. Barreto et al.   BEHAVIOURAL PHARMACOLOGY

Biological Sex Differences in Depression: A Systematic Review

(2018) Ainitze Labaka et al.   Biological Research for Nursing

Kynurenine pathway in depression: A systematic review and meta-analysis

(2018) Kamiyu Ogyu et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Dopaminergic system activity under stress condition - seeking individual differences, preclinical studies

(2018) Marek Gryz et al.   Psychiatria Polska

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression

(2018) Qing Meng et al.   Biomolecules & Therapeutics

A review of the neurobiological underpinning of comorbid substance use and mood disorders

(2018) Nieves Gómez-Coronado et al.   JOURNAL OF AFFECTIVE DISORDERS

Reward systems and cognitions in Major Depressive Disorder

(2018) Marie-Laure Cléry-Melin et al.   CNS SPECTRUMS

A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor)

(2017) Benjamin Keller et al.   Frontiers in Psychiatry

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib

(2017) Daniela Krause et al.   Frontiers in Psychiatry

Depression, Serotonin and Tryptophan

(2016) Liliana Dell'Osso et al.   CURRENT PHARMACEUTICAL DESIGN

Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry

(2016) Josep Marcos et al.   JOURNAL OF CHROMATOGRAPHY A

Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse

(2016) Valentina Vengeliene et al.   PSYCHOPHARMACOLOGY

The Relationship of Alcohol Use Disorders and Depressive Symptoms to Tryptophan Metabolism: Cross-Sectional Data from a Nepalese Alcohol Treatment Sample

(2015) Sudan Prasad Neupane et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

The role of serotonin in drug use and addiction

(2015) Christian P. Müller et al.   BEHAVIOURAL BRAIN RESEARCH

Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders

(2015) James A. Foulds et al.   JOURNAL OF AFFECTIVE DISORDERS

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

(2015) Gislaine Z. Réus et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity

(2015) María Pedraz et al.   PLoS One

Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?

(2014) Jacqueline Quak et al.   PSYCHONEUROENDOCRINOLOGY

The moderating influence of nicotine and smoking on resting-state mood and EEG changes in remitted depressed patients during tryptophan depletion

(2013) Verner Knott et al.   BIOLOGICAL PSYCHOLOGY

Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments

(2013) Gregory Oxenkrug   CURRENT DRUG TARGETS

PROSPECTIVE STUDY OF SUBSTANCE-INDUCED AND INDEPENDENT MAJOR DEPRESSIVE DISORDER AMONG INDIVIDUALS WITH SUBSTANCE USE DISORDERS IN A NATIONALLY REPRESENTATIVE SAMPLE

(2013) Jessica F. Magidson et al.   DEPRESSION AND ANXIETY

Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects

(2013) Simon Young et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence

(2012) Sharon Samet et al.   ADDICTION

Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target

(2012) Helen M. Pettinati et al.   AMERICAN JOURNAL OF PSYCHIATRY

Indoleamine 2,3-Dioxygenase Activation and Depressive Symptoms

(2012) Marko Elovainio et al.   PSYCHOSOMATIC MEDICINE

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder

(2011) M. Elizabeth Sublette et al.   BRAIN BEHAVIOR AND IMMUNITY

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

(2010) Michael Maes   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Major depression and comorbid substance use disorders

(2009) Lori Davis et al.   CURRENT OPINION IN PSYCHIATRY

Cognitive control of drug craving inhibits brain reward regions in cocaine abusers

(2009) Nora D. Volkow et al.   NEUROIMAGE

Neuroplasticity in the mesolimbic dopamine system and cocaine addiction

(2008) M J Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE